Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
Peigang Wang, Dongjiang Tang, Zhan Hua, Zai Wang, Jing An
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakSars virusSunitinibPandemicCoronavirusMedicineOutbreakInfectious disease (medical specialty)Internal medicineDiseaseCancerCOVID-19 Clinical Research StudiesPhagocytosis and Immune RegulationSARS-CoV-2 and COVID-19 Research